Grand Pharmaceutical Group Limited (HKG:0512)

Market Cap	18.35B -26.3%
Revenue (ttm)	12.28B +5.5%
Net Income	1.24B -49.7%
EPS	0.35 -49.7%
Shares Out	3.50B
PE Ratio	14.79
Forward PE	9.19
Dividend	0.17 (3.23%)
Ex-Dividend Date	Jun 12, 2026

Volume	10,485,000
Open	5.32
Previous Close	5.24
Day's Range	5.21 - 5.39
52-Week Range	5.13 - 10.20
Beta	0.74
Analysts	Strong Buy
Price Target	11.90 (+122.85%)
Earnings Date	Jun 2, 2026

About HKG:0512

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additive...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 12,614
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0512

Financial Performance

In 2025, HKG:0512's revenue was 12.28 billion, an increase of 5.48% compared to the previous year's 11.64 billion. Earnings were 1.24 billion, a decrease of -49.73%.